Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 1999, p. 1914-1918, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Analysis of Vancomycin Population Susceptibility
Profiles, Killing Activity, and Postantibiotic Effect against
Vancomycin-Intermediate Staphylococcus aureus
Jeffrey R.
Aeschlimann,1,2,
Ellie
Hershberger,1,2 and
Michael J.
Rybak1,2,3,*
The Anti-Infective Research Laboratory,
Department of Pharmacy Services, Detroit Receiving Hospital and
University Health Center,1 and College
of Pharmacy and Allied Health Professions2 and
School of Medicine,3 Wayne State
University, Detroit, Michigan 48201
Received 20 November 1998/Returned for modification 15 April
1999/Accepted 27 May 1999
Methicillin-resistant Staphylococcus aureus strains
with decreased vancomycin susceptibility have been isolated from
patients in the United States and Japan. The impact of decreased
vancomycin susceptibility on the drug's pharmacodynamic parameters has
not been addressed. We studied the activity of vancomycin against three
clinical strains of vancomycin intermediate-susceptible Staphylococcus aureus (VISA) under high- and low-inoculum
conditions, with stationary- and logarithmic-growth-phase kill curves,
and in postantibiotic effect (PAE) experiments. We also investigated the stability of the decreased vancomycin susceptibility by using population susceptibility profiles. The respective vancomycin microdilution MICs and MBCs for VISA strains HIP5836, 14379, and Mu50
were 8 and 8, 8 and 8, and 8 and 16 µg/ml. HIP5836 had the most
homogeneous elevation of vancomycin MICs, because the MIC for nearly
all bacteria in the inoculum was 8 µg/ml. The population MICs
(defined as the lowest vancomycin concentration inhibiting 99.9% of
growth) for the first serial passages of HIP5836, Mu50, and 14379 were
8, 4, and 2 µg/ml, respectively. After 10 passages, they decreased to
4, 2, and 1 µg/ml, respectively. The Mu50 population MIC increased to
12 µg/ml after five serial passages on vancomycin agar. In the low-
and high-inoculum kill curves, time to 99.9% killing was significantly
(P < 0.05) longer for both Mu50 and HIP5836 than that
for 14379 and a control strain. However, colony counts at 24 h
were similar to those of the vancomycin-sensitive strain for all VISA
strains. The PAE (at 4× MIC) ranged from 1.3 h for 14379 to
2.0 h for HIP5836 and was similar to or greater than the PAE
against the vancomycin-sensitive strain. In conclusion, we found that
the decreased vancomycin susceptibility increased during persistent
exposures to the drug and decreased upon removal of the selective
pressure. The decreased vancomycin susceptibility decreased the rate of
vancomycin killing, but did not affect the extent of killing or the PAE.
*
Corresponding author. Mailing address: The
Anti-Infective Research Laboratory, Department of Pharmacy Services
(1B), Detroit Receiving Hospital and University Health Center, 4201 St.
Antoine Blvd., Detroit, MI 48201. Phone: (313) 745-4554. Fax: (313)
993-2522. E-mail: mrybak{at}dmc.org.
Present address: The University of Connecticut, School of Pharmacy,
Storrs, CT 06269.
Antimicrobial Agents and Chemotherapy, August 1999, p. 1914-1918, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Rybak, M. J., Leonard, S. N., Rossi, K. L., Cheung, C. M., Sadar, H. S., Jones, R. N.
(2008). Characterization of Vancomycin-Heteroresistant Staphylococcus aureus from the Metropolitan Area of Detroit, Michigan, over a 22-Year Period (1986 to 2007). J. Clin. Microbiol.
46: 2950-2954
[Abstract]
[Full Text]
-
Butler, M. M., LaMarr, W. A., Foster, K. A., Barnes, M. H., Skow, D. J., Lyden, P. T., Kustigian, L. M., Zhi, C., Brown, N. C., Wright, G. E., Bowlin, T. L.
(2007). Antibacterial Activity and Mechanism of Action of a Novel Anilinouracil-Fluoroquinolone Hybrid Compound. Antimicrob. Agents Chemother.
51: 119-127
[Abstract]
[Full Text]
-
Sieradzki, K., Tomasz, A.
(2003). Alterations of Cell Wall Structure and Metabolism Accompany Reduced Susceptibility to Vancomycin in an Isogenic Series of Clinical Isolates of Staphylococcus aureus. J. Bacteriol.
185: 7103-7110
[Abstract]
[Full Text]
-
Pavie, J., Lefort, A., Ploy, M.-C., Massias, L., Chau, F., Garry, L., Denis, F., Fantin, B.
(2003). Influence of Reduced Susceptibility to Glycopeptides on Activities of Vancomycin and Teicoplanin against Staphylococcus aureus in Experimental Endocarditis. Antimicrob. Agents Chemother.
47: 2018-2021
[Abstract]
[Full Text]
-
Cha, R., Grucz, R. G. Jr., Rybak, M. J.
(2003). Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms. Antimicrob. Agents Chemother.
47: 1598-1603
[Abstract]
[Full Text]
-
Isnansetyo, A., Kamei, Y.
(2003). MC21-A, a Bactericidal Antibiotic Produced by a New Marine Bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30T, against Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
47: 480-488
[Abstract]
[Full Text]
-
Reipert, A., Ehlert, K., Kast, T., Bierbaum, G.
(2003). Morphological and Genetic Differences in Two Isogenic Staphylococcus aureus Strains with Decreased Susceptibilities to Vancomycin. Antimicrob. Agents Chemother.
47: 568-576
[Abstract]
[Full Text]
-
Butler, M. M., Skow, D. J., Stephenson, R. O., Lyden, P. T., LaMarr, W. A., Foster, K. A.
(2002). Low Frequencies of Resistance among Staphylococcus and Enterococcus Species to the Bactericidal DNA Polymerase Inhibitor N3-Hydroxybutyl 6-(3'-Ethyl-4'-Methylanilino) Uracil. Antimicrob. Agents Chemother.
46: 3770-3775
[Abstract]
[Full Text]
-
Kim, M.-N., Hwang, S. H., Pyo, Y.-J., Mun, H.-M., Pai, C. H.
(2002). Clonal Spread of Staphylococcus aureus Heterogeneously Resistant to Vancomycin in a University Hospital in Korea. J. Clin. Microbiol.
40: 1376-1380
[Abstract]
[Full Text]
-
Vaudaux, P., Francois, P., Berger-Bachi, B., Lew, D. P.
(2001). In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus. J Antimicrob Chemother
47: 163-170
[Abstract]
[Full Text]
-
Aeschlimann, J. R., Allen, G. P., Hershberger, E., Rybak, M. J.
(2000). Activities of LY333328 and Vancomycin Administered Alone or in Combination with Gentamicin against Three Strains of Vancomycin-Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model. Antimicrob. Agents Chemother.
44: 2991-2998
[Abstract]
[Full Text]
-
Biavasco, F., Vignaroli, C., Lazzarini, R., Varaldo, P. E.
(2000). Glycopeptide Susceptibility Profiles of Staphylococcus haemolyticus Bloodstream Isolates. Antimicrob. Agents Chemother.
44: 3122-3126
[Abstract]
[Full Text]
-
Cui, L., Murakami, H., Kuwahara-Arai, K., Hanaki, H., Hiramatsu, K.
(2000). Contribution of a Thickened Cell Wall and Its Glutamine Nonamidated Component to the Vancomycin Resistance Expressed by Staphylococcus aureus Mu50. Antimicrob. Agents Chemother.
44: 2276-2285
[Abstract]
[Full Text]
-
Akins, R. L., Rybak, M. J.
(2000). In Vitro Activities of Daptomycin, Arbekacin, Vancomycin, and Gentamicin Alone and/or in Combination against Glycopeptide Intermediate-Resistant Staphylococcus aureus in an Infection Model. Antimicrob. Agents Chemother.
44: 1925-1929
[Abstract]
[Full Text]
-
Aeschlimann, J. R., Hershberger, E., Rybak, M. J.
(2000). Activities of Trovafloxacin and Ampicillin-Sulbactam Alone or in Combination versus Three Strains of Vancomycin- Intermediate Staphylococcus aureus in an In Vitro Pharmacodynamic Infection Model. Antimicrob. Agents Chemother.
44: 1153-1158
[Abstract]
[Full Text]